Pittenger & Anderson Inc. Buys 2,270 Shares of HCA Healthcare, Inc. $HCA

Pittenger & Anderson Inc. grew its stake in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 75,666.7% in the first quarter, Holdings Channel reports. The institutional investor owned 2,273 shares of the company’s stock after purchasing an additional 2,270 shares during the period. Pittenger & Anderson Inc.’s holdings in HCA Healthcare were worth $1,076,000 as of its most recent filing with the SEC.

Other large investors have also recently added to or reduced their stakes in the company. Fifth Third Bancorp lifted its position in shares of HCA Healthcare by 262.1% in the 1st quarter. Fifth Third Bancorp now owns 34,688 shares of the company’s stock worth $16,416,000 after acquiring an additional 25,108 shares during the period. Markel Group Inc. raised its stake in shares of HCA Healthcare by 2.2% in the first quarter. Markel Group Inc. now owns 82,430 shares of the company’s stock valued at $39,009,000 after purchasing an additional 1,750 shares in the last quarter. Simplicity Wealth LLC boosted its stake in HCA Healthcare by 81.4% during the first quarter. Simplicity Wealth LLC now owns 880 shares of the company’s stock worth $417,000 after buying an additional 395 shares in the last quarter. Sequoia Financial Advisors LLC raised its stake in shares of HCA Healthcare by 12.9% in the 1st quarter. Sequoia Financial Advisors LLC now owns 6,100 shares of the company’s stock valued at $2,887,000 after buying an additional 698 shares in the last quarter. Finally, Cedar Mountain Advisors LLC acquired a new stake in shares of HCA Healthcare during the 1st quarter valued at about $33,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analysts Set New Price Targets

HCA has been the topic of a number of recent research reports. KeyCorp decreased their price objective on HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating on the stock in a report on Monday, April 27th. Leerink Partners dropped their price objective on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a research note on Monday, April 27th. Robert W. Baird reduced their target price on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 15th. Stephens cut their price target on shares of HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a report on Monday, April 27th. Finally, Truist Financial set a $413.00 price objective on shares of HCA Healthcare in a report on Thursday, June 4th. Fourteen equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $497.14.

View Our Latest Research Report on HCA Healthcare

HCA Healthcare Trading Down 0.0%

HCA opened at $406.45 on Monday. HCA Healthcare, Inc. has a 1-year low of $330.00 and a 1-year high of $556.52. The firm has a 50-day moving average price of $397.56 and a two-hundred day moving average price of $460.31. The stock has a market capitalization of $90.17 billion, a PE ratio of 13.98, a PEG ratio of 1.29 and a beta of 1.12.

HCA Healthcare (NYSE:HCAGet Free Report) last released its quarterly earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. During the same period last year, the company earned $6.45 earnings per share. HCA Healthcare’s revenue for the quarter was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, research analysts predict that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th were paid a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend was Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is 10.73%.

About HCA Healthcare

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Read More

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.